Nina Lin, MD
Assistant Professor
Boston University School of Medicine
Dept of Medicine
Infectious Diseases Section

MD, Harvard Medical School



Dr. Nina Lin is a physician scientist who is engaged in HIV translational research. Her research is focused on understanding the effect of chronic HIV infection on aging of the immune system and chronic inflammation. She is the PI on several clinical trials, including being a co-Chair of ACTG A5325 and A5220s, to evaluate interventions which may improve or alter the clinical course of chronic HIV infection. Her research while at MGH/BWH had been on understanding HIV-1 coreceptor usage in subtype C infection and the factors associated with its switching. She is the Director of the BU Infectious Disease Clinical Research Unit (CRU) where several HIV and/or infectious diseases clinical studies are being conducted.


Impact of smoking and its cessation on systemic and airway immune activation
08/15/2016 - 06/30/2017 (Co-PI)
PI: Avrum Spira, MD
Boston Medical Center Corporation NIH NIDA
1R01DA042685-01


Impact of smoking and its cessation on systemic and airway immune activation
08/15/2016 - 06/30/2021 (PI)
NIH-NIDA
1R01DA042685-01

A Phase 3, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Switching from Reg…
05/18/2016 - 05/17/2018 (PI)
Gilead Sciences

REPRIEVE
05/01/2015 - 04/30/2018 (PI)
Mass General Hosp NIH-NHLBI
U01HL023336

Combining social network, spatial, and phylogenetic approaches to identify new HIV infections
02/15/2017 - 01/31/2018 (PI)
Trustees of Boston University NIH-NIAID

Intensified antiretroviral therapy with raltegravir in acute HIV infection to limit establishment…
12/10/2014 - 12/09/2017 (PI)
Merck

A Phase 3, Randomized, Double-Blind Study to Evaluate Switching from a Regimen containing Doluteg…
05/16/2016 - 05/31/2017 (PI)
Gilead Sciences

GS-US-366-1160: a Phase 3b, Randomized, Souble-Blind Study to Evaluate Switching from a Regimen
06/17/2015 - 05/31/2017 (PI)
Gilead Sciences

Ragon Clinical Platform
01/01/2015 - 12/31/2016 (PI)
Mass General Hosp

Analysis of properties of HIV-1 subtype C envelope glycoprotein
06/01/2014 - 04/30/2016 (PI)
NIH-NIAID
6K08AI081545-06

Reprieve- Supplemental Funding
05/01/2015 - 11/30/2015 (PI)
Brigham & Women's NIH-NIAID


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Lin N, Gonzalez OA, Registre L, Becerril C, Etemad B, Lu H, Wu X, Lockman S, Essex M, Moyo S, Kuritzkes DR, Sagar M. Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants. EBioMedicine. 2016 Jun; 8:237-47.View Related Profiles. PMID: 27428434; PMCID: PMC4919596; DOI: 10.1016/j.ebiom.2016.04.040;.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 1 publications over 1 distinct years, with a maximum of 1 publications in 2016

YearPublications
20161
Contact for Mentoring:


650 Albany St Evans Biomed Research Ctr
Boston MA 02118
Google Map


Lin's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department